Tolremo Therapeutics
ID: 7648452Tolremo Therapeutics is a cancer Resistance Prevention.
8
Funding Rounds
$81.9m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Tolremo Therapeutics has raised a total of $81.9m in funding over 8 rounds.
Key Insights:
- TOLREMO therapeutics September 2023 Series A Funding Round: $20m
- TOLREMO therapeutics September 2023 Series A Funding Round: $20m
- TOLREMO therapeutics June 2020 Series A Funding Round: $5.1m
- TOLREMO therapeutics June 2020 Series A Funding Round: $5.1m
- TOLREMO therapeutics September 2018 Series A Funding Round: $9.9m
- TOLREMO therapeutics September 2018 Series A Funding Round: $9.9m
- Tolremo Therapeutics Series A round, September 2018: $9.3m
- TOLREMO therapeutics September 2017 Seed Funding Round: $2.6m
Industries
Tolremo Therapeutics is active in the following industries: